JAKAFI XR

Product NDC: 50881-044
Requested package NDC: 50881-044-08
11-digit product format: 508810044
Labeler code: 50881
Product ID: 50881-044_baf91401-9bd0-4ce6-a5c4-7ca5c572f106
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: ruxolitinib
Dosage form: TABLET, EXTENDED RELEASE
Route: ORAL
Labeler: Incyte Corporation
Application: NDA217180
Marketing category: NDA
Marketing start: 2026-05-01
Substance: RUXOLITINIB
Active strength: 44 mg/1
Pharmacologic classes: Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N217180-001	JAKAFI XR	RUXOLITINIB PHOSPHATE	EQ 11MG BASE	TABLET, EXTENDED RELEASE / ORAL	RLD	2026-05-01
N217180-002	JAKAFI XR	RUXOLITINIB PHOSPHATE	EQ 22MG BASE	TABLET, EXTENDED RELEASE / ORAL	RLD	2026-05-01
N217180-003	JAKAFI XR	RUXOLITINIB PHOSPHATE	EQ 33MG BASE	TABLET, EXTENDED RELEASE / ORAL	RLD	2026-05-01
N217180-004	JAKAFI XR	RUXOLITINIB PHOSPHATE	EQ 44MG BASE	TABLET, EXTENDED RELEASE / ORAL	RLD	2026-05-01
N217180-005	JAKAFI XR	RUXOLITINIB PHOSPHATE	EQ 55MG BASE	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2026-05-01

Orange Book patents#

Current patent rows page 1 of 4 · 265 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N217180-001	11744832	2026-12-12	U-3226		2026-05-28
N217180-001	11744832	2026-12-12	U-3230		2026-05-28
N217180-001	8530485	2026-12-12		Drug product	2026-05-28
N217180-001	9079912	2026-12-12	U-3226		2026-05-28
N217180-001	9079912	2026-12-12	U-3227		2026-05-28
N217180-001	9079912	2026-12-12	U-3228		2026-05-28
N217180-001	9079912	2026-12-12	U-3230		2026-05-28
N217180-001	9206187	2026-12-12	U-3227		2026-05-28
N217180-001	9206187	2026-12-12	U-3228		2026-05-28
N217180-001	9814722	2026-12-12	U-3226		2026-05-28
N217180-001	9814722	2026-12-12	U-3230		2026-05-28
N217180-001	7598257	2027-12-24	U-3227	Drug substance, Drug product	2026-05-28
N217180-001	7598257	2027-12-24	U-3228	Drug substance, Drug product	2026-05-28
N217180-001	8415362	2027-12-24		Drug substance, Drug product	2026-05-28
N217180-001	10016429	2028-06-12	U-3226		2026-05-28
N217180-001	10016429	2028-06-12	U-3230		2026-05-28
N217180-001	11213528	2028-06-12		Drug product	2026-05-28
N217180-001	8722693	2028-06-12		Drug substance, Drug product	2026-05-28
N217180-001	8822481	2028-06-12	U-3226		2026-05-28
N217180-001	8822481	2028-06-12	U-3227		2026-05-28
N217180-001	8822481	2028-06-12	U-3228		2026-05-28
N217180-001	8822481	2028-06-12	U-3230		2026-05-28
N217180-001	8829013	2028-06-12	U-3227		2026-05-28
N217180-001	8829013	2028-06-12	U-3228		2026-05-28
N217180-001	7598257*PED	2028-06-24		Pediatric extension
N217180-001	8415362*PED	2028-06-24		Pediatric extension
N217180-001	10016429*PED	2028-12-12		Pediatric extension
N217180-001	11213528*PED	2028-12-12		Pediatric extension
N217180-001	8722693*PED	2028-12-12		Pediatric extension
N217180-001	8822481*PED	2028-12-12		Pediatric extension
N217180-001	8829013*PED	2028-12-12		Pediatric extension
N217180-001	10874616	2033-11-14		Drug product	2026-05-28
N217180-001	11576864	2033-11-14	U-3226		2026-05-28
N217180-001	11576864	2033-11-14	U-3227		2026-05-28
N217180-001	11576864	2033-11-14	U-3228		2026-05-28
N217180-001	11576864	2033-11-14	U-3230		2026-05-28
N217180-001	11576865	2033-11-14	U-3226	Drug product	2026-05-28
N217180-001	11576865	2033-11-14	U-3227	Drug product	2026-05-28
N217180-001	11576865	2033-11-14	U-3228	Drug product	2026-05-28
N217180-001	11576865	2033-11-14	U-3230	Drug product	2026-05-28
N217180-001	11896717	2033-11-14	U-3226	Drug product	2026-05-28
N217180-001	11896717	2033-11-14	U-3227	Drug product	2026-05-28
N217180-001	11896717	2033-11-14	U-3228	Drug product	2026-05-28
N217180-001	11896717	2033-11-14	U-3230	Drug product	2026-05-28
N217180-001	11337927	2034-01-17	U-3226		2026-05-28
N217180-001	11337927	2034-01-17	U-3227		2026-05-28
N217180-001	11337927	2034-01-17	U-3228		2026-05-28
N217180-001	11337927	2034-01-17	U-3230		2026-05-28
N217180-001	10874616*PED	2034-05-14		Pediatric extension
N217180-001	11576864*PED	2034-05-14		Pediatric extension
N217180-001	11576865*PED	2034-05-14		Pediatric extension
N217180-001	11896717*PED	2034-05-14		Pediatric extension
N217180-001	11337927*PED	2034-07-17		Pediatric extension
N217180-002	11744832	2026-12-12	U-3226		2026-05-28
N217180-002	11744832	2026-12-12	U-3230		2026-05-28
N217180-002	8530485	2026-12-12		Drug product	2026-05-28
N217180-002	9079912	2026-12-12	U-3226		2026-05-28
N217180-002	9079912	2026-12-12	U-3227		2026-05-28
N217180-002	9079912	2026-12-12	U-3228		2026-05-28
N217180-002	9079912	2026-12-12	U-3230		2026-05-28
N217180-002	9206187	2026-12-12	U-3227		2026-05-28
N217180-002	9206187	2026-12-12	U-3228		2026-05-28
N217180-002	9814722	2026-12-12	U-3226		2026-05-28
N217180-002	9814722	2026-12-12	U-3230		2026-05-28
N217180-002	7598257	2027-12-24	U-3227	Drug substance, Drug product	2026-05-28
N217180-002	7598257	2027-12-24	U-3228	Drug substance, Drug product	2026-05-28
N217180-002	8415362	2027-12-24		Drug substance, Drug product	2026-05-28
N217180-002	10016429	2028-06-12	U-3226		2026-05-28
N217180-002	10016429	2028-06-12	U-3230		2026-05-28
N217180-002	11213528	2028-06-12		Drug product	2026-05-28
N217180-002	8722693	2028-06-12		Drug substance, Drug product	2026-05-28
N217180-002	8822481	2028-06-12	U-3226		2026-05-28
N217180-002	8822481	2028-06-12	U-3227		2026-05-28
N217180-002	8822481	2028-06-12	U-3228		2026-05-28
N217180-002	8822481	2028-06-12	U-3230		2026-05-28
N217180-002	8829013	2028-06-12	U-3227		2026-05-28
N217180-002	8829013	2028-06-12	U-3228		2026-05-28
N217180-002	7598257*PED	2028-06-24		Pediatric extension
N217180-002	8415362*PED	2028-06-24		Pediatric extension
N217180-002	10016429*PED	2028-12-12		Pediatric extension

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 10 matching rows.

Application-product, Exclusivity code, Expiration table
Application-product	Exclusivity code	Expiration
N217180-001	ODE*	2028-09-22
N217180-001	PED	2029-03-22
N217180-002	ODE*	2028-09-22
N217180-002	PED	2029-03-22
N217180-003	ODE*	2028-09-22
N217180-003	PED	2029-03-22
N217180-004	ODE*	2028-09-22
N217180-004	PED	2029-03-22
N217180-005	ODE*	2028-09-22
N217180-005	PED	2029-03-22

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	JAKAFI XR	EQ 11MG BASE	TABLET, EXTENDED RELEASE / ORAL	RLD	2026-05-01	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-002	JAKAFI XR	EQ 22MG BASE	TABLET, EXTENDED RELEASE / ORAL	RLD	2026-05-01	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-003	JAKAFI XR	EQ 33MG BASE	TABLET, EXTENDED RELEASE / ORAL	RLD	2026-05-01	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-004	JAKAFI XR	EQ 44MG BASE	TABLET, EXTENDED RELEASE / ORAL	RLD	2026-05-01	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-005	JAKAFI XR	EQ 55MG BASE	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2026-05-01	`a50c72e98297…`

Observed Orange Book patent history#

Patent history page 1 of 7 · 265 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	11744832	2026-12-12	U-3226		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	11744832	2026-12-12	U-3230		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	8530485	2026-12-12		Drug product	2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	9079912	2026-12-12	U-3227		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	9079912	2026-12-12	U-3228		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	9079912	2026-12-12	U-3230		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	9079912	2026-12-12	U-3226		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	9206187	2026-12-12	U-3227		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	9206187	2026-12-12	U-3228		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	9814722	2026-12-12	U-3226		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	9814722	2026-12-12	U-3230		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	7598257	2027-12-24	U-3227	Drug substance, Drug product	2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	7598257	2027-12-24	U-3228	Drug substance, Drug product	2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	8415362	2027-12-24		Drug substance, Drug product	2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	10016429	2028-06-12	U-3226		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	10016429	2028-06-12	U-3230		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	11213528	2028-06-12		Drug product	2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	8722693	2028-06-12		Drug substance, Drug product	2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	8822481	2028-06-12	U-3227		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	8822481	2028-06-12	U-3228		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	8822481	2028-06-12	U-3230		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	8822481	2028-06-12	U-3226		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	8829013	2028-06-12	U-3227		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	8829013	2028-06-12	U-3228		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	7598257*PED	2028-06-24		Pediatric extension		`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	8415362*PED	2028-06-24		Pediatric extension		`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	10016429*PED	2028-12-12		Pediatric extension		`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	11213528*PED	2028-12-12		Pediatric extension		`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	8722693*PED	2028-12-12		Pediatric extension		`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	8822481*PED	2028-12-12		Pediatric extension		`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	8829013*PED	2028-12-12		Pediatric extension		`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	10874616	2033-11-14		Drug product	2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	11576864	2033-11-14	U-3227		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	11576864	2033-11-14	U-3228		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	11576864	2033-11-14	U-3230		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	11576864	2033-11-14	U-3226		2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	11576865	2033-11-14	U-3227	Drug product	2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	11576865	2033-11-14	U-3228	Drug product	2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	11576865	2033-11-14	U-3230	Drug product	2026-05-28	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	11576865	2033-11-14	U-3226	Drug product	2026-05-28	`a50c72e98297…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	ODE*	2028-09-22	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-001	PED	2029-03-22	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-002	ODE*	2028-09-22	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-002	PED	2029-03-22	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-003	ODE*	2028-09-22	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-003	PED	2029-03-22	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-004	ODE*	2028-09-22	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-004	PED	2029-03-22	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-005	ODE*	2028-09-22	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N217180-005	PED	2029-03-22	`a50c72e98297…`

Additional Listing Data#

Finished product: Yes
Brand name base: JAKAFI XR
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
RUXOLITINIB	44 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
82S8X8XX8H	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 20 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1193331	Internal RxNorm lookup
1193337	Internal RxNorm lookup
1193339	Internal RxNorm lookup
1193341	Internal RxNorm lookup
1193343	Internal RxNorm lookup
1193345	Internal RxNorm lookup
1193347	Internal RxNorm lookup
1193349	Internal RxNorm lookup
1193351	Internal RxNorm lookup
1193353	Internal RxNorm lookup
2743012	Internal RxNorm lookup
2743016	Internal RxNorm lookup
2743019	Internal RxNorm lookup
2743022	Internal RxNorm lookup
2743025	Internal RxNorm lookup
2743028	Internal RxNorm lookup
2743032	Internal RxNorm lookup
2743035	Internal RxNorm lookup
2743041	Internal RxNorm lookup
2743044	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
f1c82580-87ae-11e0-bc84-0002a5d5c51b	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
54477ffc-bf5d-4583-bcf6-d041bdba36f1	Product name	1	20220316
95a946d8-a784-4eb7-bff4-2194e4331c6f	Product name	1	20190828

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50881-044-08	JAKAFI XR	30 in 1 BOTTLE, PLASTIC	TABLET, EXTENDED RELEASE	30		40

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
RUXOLITINIB	ACTIVE INGREDIENT	82S8X8XX8H	JAKAFI (RUXOLITINIB) TABLET [INCYTE CORPORATION]	13
RUXOLITINIB	ACTIVE MOIETY	82S8X8XX8H	JAKAFI (RUXOLITINIB) TABLET [INCYTE CORPORATION]	13
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	JAKAFI (RUXOLITINIB) TABLET [INCYTE CORPORATION]	13
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	JAKAFI (RUXOLITINIB) TABLET [INCYTE CORPORATION]	13
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	JAKAFI (RUXOLITINIB) TABLET [INCYTE CORPORATION]	13
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	JAKAFI (RUXOLITINIB) TABLET [INCYTE CORPORATION]	13
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	JAKAFI (RUXOLITINIB) TABLET [INCYTE CORPORATION]	13
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	JAKAFI (RUXOLITINIB) TABLET [INCYTE CORPORATION]	13
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	JAKAFI (RUXOLITINIB) TABLET [INCYTE CORPORATION]	13

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
JAKAFI	RUXOLITINIB	Incyte Corporation	f1c82580-87ae-11e0-bc84-0002a5d5c51b	2026-07-20	Warnings, Adverse reactions	Exact identifier application applno (NDA): 217180 application number: NDA217180 ndc (package): 50881-044-08 ndc (product): 50881-044 ndc11 (package): 50881004408

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
82S8X8XX8H	RUXOLITINIB	941678-49-5	RUXOLITINIB

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1193337	Jakafi 10 MG Oral Tablet	PSN	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193345	Jakafi 15 MG Oral Tablet	PSN	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193349	Jakafi 20 MG Oral Tablet	PSN	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193353	Jakafi 25 MG Oral Tablet	PSN	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193341	Jakafi 5 MG Oral Tablet	PSN	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743016	Jakafi XR 11 MG 24HR Extended Release Oral Tablet	PSN	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743022	Jakafi XR 22 MG 24HR Extended Release Oral Tablet	PSN	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743028	Jakafi XR 33 MG 24HR Extended Release Oral Tablet	PSN	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743035	Jakafi XR 44 MG 24HR Extended Release Oral Tablet	PSN	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743044	Jakafi XR 55 MG 24HR Extended Release Oral Tablet	PSN	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193331	ruxolitinib 10 MG Oral Tablet	PSN	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743012	ruxolitinib 11 MG 24HR Extended Release Oral Tablet	PSN	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193343	ruxolitinib 15 MG Oral Tablet	PSN	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193347	ruxolitinib 20 MG Oral Tablet	PSN	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743019	ruxolitinib 22 MG 24HR Extended Release Oral Tablet	PSN	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193351	ruxolitinib 25 MG Oral Tablet	PSN	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743025	ruxolitinib 33 MG 24HR Extended Release Oral Tablet	PSN	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743032	ruxolitinib 44 MG 24HR Extended Release Oral Tablet	PSN	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193339	ruxolitinib 5 MG Oral Tablet	PSN	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743041	ruxolitinib 55 MG 24HR Extended Release Oral Tablet	PSN	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743016	24 HR ruxolitinib 11 MG Extended Release Oral Tablet [Jakafi]	SBD	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743022	24 HR ruxolitinib 22 MG Extended Release Oral Tablet [Jakafi]	SBD	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743028	24 HR ruxolitinib 33 MG Extended Release Oral Tablet [Jakafi]	SBD	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743035	24 HR ruxolitinib 44 MG Extended Release Oral Tablet [Jakafi]	SBD	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743044	24 HR ruxolitinib 55 MG Extended Release Oral Tablet [Jakafi]	SBD	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193337	ruxolitinib 10 MG Oral Tablet [Jakafi]	SBD	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193345	ruxolitinib 15 MG Oral Tablet [Jakafi]	SBD	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193349	ruxolitinib 20 MG Oral Tablet [Jakafi]	SBD	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193353	ruxolitinib 25 MG Oral Tablet [Jakafi]	SBD	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193341	ruxolitinib 5 MG Oral Tablet [Jakafi]	SBD	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743012	24 HR ruxolitinib 11 MG Extended Release Oral Tablet	SCD	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743019	24 HR ruxolitinib 22 MG Extended Release Oral Tablet	SCD	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743025	24 HR ruxolitinib 33 MG Extended Release Oral Tablet	SCD	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743032	24 HR ruxolitinib 44 MG Extended Release Oral Tablet	SCD	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743041	24 HR ruxolitinib 55 MG Extended Release Oral Tablet	SCD	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193331	ruxolitinib 10 MG Oral Tablet	SCD	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193343	ruxolitinib 15 MG Oral Tablet	SCD	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193347	ruxolitinib 20 MG Oral Tablet	SCD	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193351	ruxolitinib 25 MG Oral Tablet	SCD	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193339	ruxolitinib 5 MG Oral Tablet	SCD	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193337	Jakafi (as ruxolitinib phosphate) 10 MG Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193337	Jakafi 10 MG Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193345	Jakafi 15 MG Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193349	Jakafi 20 MG Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193353	Jakafi 25 MG Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193341	Jakafi 5 MG Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743016	Jakafi XR 11 MG 24 HR Extended Release Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743022	Jakafi XR 22 MG 24 HR Extended Release Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743028	Jakafi XR 33 MG 24 HR Extended Release Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743035	Jakafi XR 44 MG 24 HR Extended Release Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743044	Jakafi XR 55 MG 24 HR Extended Release Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193331	ruxolitinib (as ruxolitinib phosphate) 10 MG Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193343	ruxolitinib (as ruxolitinib phosphate) 15 MG Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193347	ruxolitinib (as ruxolitinib phosphate) 20 MG Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193351	ruxolitinib (as ruxolitinib phosphate) 25 MG Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
1193339	ruxolitinib (as ruxolitinib phosphate) 5 MG Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743012	ruxolitinib 11 MG 24 HR Extended Release Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743019	ruxolitinib 22 MG 24 HR Extended Release Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743025	ruxolitinib 33 MG 24 HR Extended Release Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743032	ruxolitinib 44 MG 24 HR Extended Release Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40
2743041	ruxolitinib 55 MG 24 HR Extended Release Oral Tablet	SY	f1c82580-87ae-11e0-bc84-0002a5d5c51b	40

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Sample	Exclude flag	Status
50881-044-08	50881004408	30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-044-08)	2026-05-01	No	No	Current